Cell Therapy News Volume 24.39 | Dec 11 2023

    0
    24








    2023-12-11 | CTN 24.39


    Cell Therapy News by STEMCELL Technologies
    Vol. 24.39 – 11 December, 2023
    TOP STORY

    Safety and Stable Survival of Stem-Cell-Derived Retinal Organoid for 2 Years in Patients with Retinitis Pigmentosa

    The authors performed allogeneic induced pluripotent stem cell-derived retinal organoid sheet transplantation in two subjects with advanced retinitis pigmentosa.
    [Cell Stem Cell]

    AbstractGraphical Abstract
    PUBLICATIONSRanked by the impact factor of the journal

    Microfluidic Fabrication of MicroRNA-Induced Hepatocyte-Like Cells/Human Umbilical Vein Endothelial Cells-Laden Microgels for Acute Liver Failure Treatment

    Researchers designed a Y-shaped DNA nanostructure to deliver microRNA-122, which could induce the hepatic differentiation and maturation of human mesenchymal stem cells.
    [ACS Nano ]

    Full ArticleGraphical Abstract

    Leukemia-Intrinsic Determinants of CAR-T Response Revealed by Iterative In Vivo Genome-Wide CRISPR Screening

    To investigate leukemia-intrinsic CAR-T resistance mechanisms, scientists performed genome-wide CRISPR-Cas9 loss-of-function screens in an immunocompetent murine model of B cell acute lymphoblastic leukemia utilizing a modular guide RNA library.
    [Nature Communications]

    Full Article

    In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism

    Investigators developed an in vivo CAR T cell engineering platform to streamline production while using mRNA to induce transient, tunable CAR expression.
    [Small]

    Abstract

    In Vivo Safety and Biodistribution Profile of Klotho-Enhanced Human Urine-Derived Stem Cells for Clinical Application

    Researchers evaluated the in vivo safety and distribution of Klotho-enhanced urine-derived stem cells after intravenous administration in accordance with Good Laboratory Practice regulations.
    [Stem Cell Research & Therapy]

    Full Article

    Umbilical Cord-Derived Mesenchymal Stem Cell Sheets Transplanted Subcutaneously Enhance Cell Retention and Survival More than Dissociated Stem Cell Injections

    Scientists compared human umbilical cord-mesenchymal stem cell (hUC-MSC) in vivo engraftment efficacy and cytokine expression for both hUC-MSC sheets and cell suspensions.
    [Stem Cell Research & Therapy]

    Abstract

    Lipid Nanoparticles Efficiently Deliver a Trimeric Spike-Encoded DNA Vaccine to Robustly Induce Anti-SARS-CoV-2 Immunity Superior to the mRNA Vaccine in Syrian Hamsters

    Investigators reported that plasmid encoding a trimeric spike protein with lipid nanoparticle delivery (pTS/LNP), similar to those in Moderna’s COVID-19 vaccine, induced more effective humoral responses than naked pTS or pTS delivered via electroporation.
    [Molecular Therapy-Methods & Clinical Development]

    AbstractFull ArticleGraphical Abstract

    Decellularized Small Intestine Scaffolds: A Potential Xenograft for Restoration of Intestinal Perforation

    A novel strategy was demonstrated, that utilized the xenogeneic, decellularized goat small intestine as a patch for small intestine regeneration in cases of intestinal perforation.
    [Tissue Barriers]

    Abstract

    Therapeutic Effect of Adipose-Derived Stem Cells Injected into Pericardial Cavity in Rat Heart Failure

    Scientists investigated the therapeutic efficacy and evidence of cell migration of adipose-derived stem cells injected into the pericardial cavity in rat heart failure.
    [ESC Heart Failure]

    Full Article
    Explore tools and resources for your return to the lab
    REVIEWS

    CAR-T Cell Immunotherapy for Ovarian Cancer: Hushing the Silent Killer

    Investigators outline the principles of CAR-T therapy and then highlight its limitations in the context of solid tumors. They focus on preclinical and clinical findings achieved in CAR-T-mediated targeting of different ovarian cancer-associated target antigens.
    [Frontiers In Immunology]

    Full Article
    INDUSTRY AND POLICY NEWS

    Bristol Myers Squibb’s Abecma® Becomes First CAR T Approved for Use in Earlier Lines of Therapy for Patients with Relapsed or Refractory Multiple Myeloma in Japan

    Bristol-Myers Squibb K.K. announced that the company has received manufacturing and marketing approval of the supplemental New Drug Application for an additional indication for Abecma®, a B cell maturation antigen-directed CAR T cell immunotherapy.
    [Bristol-Myers Squibb K.K.]

    Press Release

    Experts in Transplantation, Engineered Cells and Pediatrics Join Growing Roswell Park Cell Therapy Program

    Three physician-scientists who have relocated to Buffalo, New York, to join Roswell Park Comprehensive Cancer Center will apply highly specialized transplantation and cell therapy expertise to both patient care and the development of New York State’s first cell therapy manufacturing and research hub.
    [Roswell Park]

    Press Release
    FEATURED EVENT

    Stem Cells and Regeneration

    January 22 – 25, 2024
    Santa Fe, New Mexico, United States

    > See All Events

    JOB OPPORTUNITIES

    Junior Research Fellow – Microdroplets for Single-Cell Sensing

    International Iberian Nanotechnology Laboratory – Braga, Portugal

    Postdoctoral Scientist – Corneal Regenerative Medicine

    Cedars-Sinai Board – Anaheim, California, United States

    PhD Positions – Tissue Regeneration and Cancer Immunotherapy

    Albert-Ludwigs-University Freiburg – Freiburg im Breisgau, Germany

    Postdoctoral Fellow – CAR T Cell Cancer Therapy

    Oslo University Hospital – Oslo, Norway

    Postdoctoral Fellows and Research Associates – Genome of Cancers

    Weill Cornell Medicine – New York City, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2